414 papers found
Refreshing results…
The effects and preventability of 2627 patient safety incidents related to health information technology failures: a retrospective analysis of 10 years of incident reporting in England and Wales
A regulatory perspective on the influence of health information technology on organisational quality and safety in England
Evaluating the impact of organisational digital maturity on clinical outcomes in secondary care in England
Exploring mobile working in healthcare: Clinical perspectives on transitioning to a mobile first culture of work
Feasibility of Intraprostatic Prostate Cancer Imaging with FCH-PET/CT for Preoperative Planning of Image-Guided HDR Brachytherapy
The Impact of Dose to Bladder Neck on Urinary Toxicity in Patients Treated with HDR Brachytherapy Boost for Prostate Cancer
Mp72-01 Improvements in Freedom From Progression With Short Term Androgen Deprivation Therapy and Pelvic Lymph Node Treatment Added to Prostate Bed Salvage Radiotherapy: The Nrg Oncology/Rtog 0534 Spport Trial
Impact of a dominant intraprostatic lesion (DIL) boost defined by sextant biopsy in permanent I-125 prostate implants on biochemical disease free survival (bDFS) and toxicity outcomes
Stakeholders' views of surgeon-specific mortality data
The impact of mobile technology on teamwork and communication in hospitals: a systematic review
MSC 2. What Do Patients Want to Know About Their Surgeon? Stakeholder Views of Surgeon-Specific Mortality Data
Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial
Antihypertensive medication adherence in chronic type B aortic dissection is an important consideration in the management debate
Can a Dominant Intraprostatic Lesion (DIL) Boost with Permanent I-125 Prostate Implants, Altered Outcomes and Improve Biochemical Disease-Free Survival (bDFS) in Intermediate Risk Prostate Cancer?
The Impact of Intraprostatic Calcifications on Biochemical Control after Permanent Prostate Implant
A Phase II Randomized Pilot Study Comparing High-Dose Rate Brachytherapy and Low-Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
WannaCry—a year on
Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy?
Hypofractionated, dose escalation radiotherapy for high-risk prostate cancer: The primary endpoint of a group led phase III trial. (PCS5).
Multicenter Evaluation of Biochemical Relapse–Free Survival Outcomes for Intraoperatively Planned Prostate Brachytherapy Using an Automated Delivery System
Missing publications? Read more about our data sources.